Cachexia in gynecologic cancers: The role of biomarkers and cachexia index
CXI provides a comprehensive cachexia assessment in gynecologic cancers. Elevated Activin A is linked to muscle degradation. Prehabilitation improves CXI and reduces cachexia biomarkers, emphasizing its therapeutic potential. Further validation of CXI and biomarkers may enhance cachexia diagnosis and management.
Authors
- Deepak Vats
- Saroj Rajan (ORCID: https://orcid.org/0000-0001-6563-6876)
- Seema Singhal (ORCID: https://orcid.org/0000-0002-8644-7684)
- Archana Singh (ORCID: https://orcid.org/0000-0001-5365-6351)
- Neena Malhotra (ORCID: https://orcid.org/0000-0001-7837-5361)
- Ekta Dhamija (ORCID: https://orcid.org/0000-0001-8265-9674)
Institutions
- All India Institute of Medical Sciences (IN)
Publication Details
- Journal
- International Journal of Gynecology & Obstetrics
- Published
- 2025-05-31
- DOI
- https://doi.org/10.1002/ijgo.70262
- Citations
- 1
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 1.16